Cite
HARVARD Citation
Mechtler, L. et al. (n.d.). Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine. Toxicon. pp. S40-S41. [Online].